October 25, 2018
Interim Report Q3 2018
Media
October 25, 2018
Nordic Nanovector’s Betalutin® Receives Promising Innovative Medicine (PIM) Designation in the UK for the Treatment of Follicular Lymphoma
October 24, 2018
Save the date: Orexo to host Capital Markets Day on Dec. 6 with the US president´s former advisor as key note speaker
October 24, 2018
Orexo appoints Joseph DeFeo as new CFO
October 22, 2018
Strongbridge Biopharma plc Presents Detailed Initial Results from Pivotal Phase 3 SONICS Study of RECORLEV™ (levoketoconazole) for the Treatment of Endogenous Cushing’s Syndrome at the 18th Annual Congress of the European NeuroEndocrine Association
October 22, 2018
Göran Wessman resigns from the Board – joins the Nomination Committee now appointed in Vicore Pharma Holding
October 22, 2018
BioClin Therapeutics to Participate in BTIG Biotech Conference
October 22, 2018
BONESUPPORT starts selling CERAMENT® BONE VOID FILLER Direct in the US via its own New Distributor Network
October 18, 2018
GenSight Biologics reports positive 72-week data from REVERSE Phase III clinical trial of GS010 for the treatment of Leber Hereditary Optic Neuropathy (LHON)
October 17, 2018
Nordic Nanovector ASA: Change of Date for Q3 2018 Results Presentation and Webcast
